Intco Medical Technology Co., Ltd. (SHE:300677)
China
· Delayed Price · Currency is CNY 50.41
+1.80 (3.70%)
Mar 10, 2026, 11:15 AM CST
Intco Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 31,486 | 16,222 | 15,324 | 13,870 | 31,812 | 59,156 | Upgrade
|
| Market Cap Growth | 80.53% | 5.86% | 10.48% | -56.40% | -46.22% | 1698.17% | Upgrade
|
| Enterprise Value | 27,264 | 11,386 | 10,593 | 7,078 | 23,841 | 55,521 | Upgrade
|
| Last Close Price | 48.61 | 25.14 | 23.11 | 20.71 | 46.30 | 87.97 | Upgrade
|
| PE Ratio | 18.15 | 11.07 | 40.01 | 22.05 | 4.28 | 8.44 | Upgrade
|
| Forward PE | 23.89 | 1.46 | 1.46 | 1.46 | 5.01 | 8.21 | Upgrade
|
| PS Ratio | 3.20 | 1.70 | 2.22 | 2.10 | 1.96 | 4.28 | Upgrade
|
| PB Ratio | 1.70 | 0.92 | 0.94 | 0.86 | 1.97 | 6.27 | Upgrade
|
| P/TBV Ratio | 1.81 | 0.98 | 0.99 | 0.91 | 2.09 | 6.58 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 9.83 | 10.40 | Upgrade
|
| P/OCF Ratio | 18.62 | 15.03 | 30.50 | 13.02 | 3.67 | 6.89 | Upgrade
|
| EV/Sales Ratio | 2.77 | 1.20 | 1.53 | 1.07 | 1.47 | 4.01 | Upgrade
|
| EV/EBITDA Ratio | 14.64 | 6.54 | 19.02 | 12.71 | 2.66 | 6.34 | Upgrade
|
| EV/EBIT Ratio | 30.18 | 12.86 | - | - | 2.78 | 6.44 | Upgrade
|
| EV/FCF Ratio | -26.66 | - | - | - | 7.37 | 9.76 | Upgrade
|
| Debt / Equity Ratio | 0.96 | 0.75 | 0.44 | 0.10 | 0.02 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 9.56 | 7.61 | 12.77 | 2.82 | 0.03 | 0.03 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.09 | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.31 | -0.37 | -0.42 | -0.49 | -0.65 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.44 | -3.15 | -10.80 | -12.01 | -0.89 | -0.70 | Upgrade
|
| Net Debt / FCF Ratio | 4.43 | 7.72 | 6.42 | 10.30 | -2.47 | -1.07 | Upgrade
|
| Asset Turnover | 0.27 | 0.31 | 0.28 | 0.31 | 0.97 | 1.74 | Upgrade
|
| Inventory Turnover | 5.89 | 6.08 | 5.55 | 5.55 | 6.51 | 7.94 | Upgrade
|
| Quick Ratio | 1.25 | 1.38 | 1.64 | 2.82 | 4.36 | 3.13 | Upgrade
|
| Current Ratio | 1.34 | 1.50 | 1.81 | 3.24 | 5.17 | 3.82 | Upgrade
|
| Return on Equity (ROE) | 9.84% | 8.78% | 2.40% | 3.97% | 58.38% | 128.00% | Upgrade
|
| Return on Assets (ROA) | 1.53% | 1.79% | -0.42% | -0.21% | 31.97% | 67.64% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.10% | 7.30% | -1.45% | -0.73% | 129.14% | 290.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 4.40% | -0.90% | -0.40% | 46.30% | 80.50% | Upgrade
|
| Earnings Yield | 5.41% | 9.03% | 2.50% | 4.54% | 23.36% | 11.85% | Upgrade
|
| FCF Yield | -3.25% | -4.38% | -6.11% | -4.69% | 10.17% | 9.62% | Upgrade
|
| Dividend Yield | 0.44% | 0.60% | 0.35% | 0.48% | 1.35% | 2.10% | Upgrade
|
| Payout Ratio | 25.64% | 23.08% | 48.28% | 72.66% | 14.46% | 2.32% | Upgrade
|
| Buyback Yield / Dilution | 2.99% | 1.80% | 0.28% | 1.97% | -9.01% | -13.91% | Upgrade
|
| Total Shareholder Return | 3.43% | 2.40% | 0.62% | 2.44% | -7.66% | -11.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.